Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Effects of Psilocybin in Major Depressive Disorder

To see complete record on, please visit this link

Id: NCT03181529

Organisation Name: Johns Hopkins University

Overal Status: Completed

Start Date: August 10, 2017

Last Update: December 15, 2021

Lead Sponsor: Johns Hopkins University

Brief Summary: The proposed pilot study will assess whether people with major depressive disorder experience psychological and behavioral benefits and/or harms from psilocybin. This study will investigate acute and persisting effects of psilocybin on depressive symptoms and other moods, attitudes, and behaviors. The primary hypothesis is that psilocybin will lead to rapid and sustained antidepressant response, as measured with standard depression rating scales.

  • Major Depressive Disorder

Total execution time in seconds: 0.22120690345764